BiopharmaTrend.com

GTN

GTN

Bankrupt
GTN

At GTN they are searching the astronomically large space of drug-like molecules with their unique patented technology, Generative Tensorial Networks. Their software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, halving development costs and discovering molecules entirely hidden from view.


Founded
2017
Status
Bankrupt
Geography
United Kingdom based
Funding
$2.793 M
Patents
5
Research papers
9

Products

No products posted yet

Services

No services posted yet


This data is part of our proprietary analytics report:

This service is currently only supported on the desktop screens, please, use this service from your desktop or laptop for correct visualization and functionality

Go to home page